dr. brufsky on trastuzumab and eribulin for her2 metastatic breast cancer
Published 10 years ago • 264 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
3:40
treatment with eribulin in metastatic breast cancer
-
1:38
dr. brufsky on the results of a study of trastuzumab and eribulin for her2 mbc
-
6:51
treatment with eribulin mesylate in metastatic breast cancer
-
5:25
eribulin in metastatic breast cancer
-
1:41
dr. brufsky on implementing pertuzumab in her2 breast cancer
-
1:06
dr. brufsky on challenges in breast cancer
-
2:20
dr. llombart-cussac on eribulin in her2-negative metastatic breast cancer
-
1:49
dr. brufsky discusses pertuzumab in her2 breast cancer
-
2:39
adam brufsky, md, phd, describes the treatment landscape of her2 metastatic breast cancer
-
1:13
dr. hamilton on the efficacy of trastuzumab deruxtecan in her2-low breast cancer
-
1:49
dr. brufsky on multiparametric genomic assays in breast cancer
-
1:00
dr. mcintyre on eribulin as first-line therapy in her2- breast cancer
-
2:46
dr. brufsky on the fda approval of olaparib in brca breast cancer
-
7:11
chemotherapeutics in metastatic breast cancer
-
1:30
dr. brufsky on genomic assays for breast cancer
-
2:33
dr. brufsky discusses resistance to her2-targeted therapies
-
4:37
changing treatment landscape in metastatic breast cancer
-
0:39
dr. brufsky discusses future research into bisphosphonates